Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced Envista's KaVo imaging business will be re-branded as "DEXIS". Dental professionals have known the DEXIS brand as the leader in digital intraoral radiography and diagnostic software innovation for over 20 years. The DEXIS brand will now represent a full portfolio of award-winning imaging and digital solutions including cone-beam computed tomography (CBCT), handheld x-rays, intraoral scanners, sensors, and navigated surgical solutions.
Envista has been making some "brand changes" lately, and this is their latest (at least that I am aware of). Over the years the company acquired a fair number of companies that were in the digital imaging space (as you can see in the press release below). Those companies encompassed a fair portion of the dental imaging market. I think in an effort to reduce redundancy in messaging and also to create economies of scale, Envista has now consolidated those other imaging companies and platforms into the DEXIS brand. Here are all the details, straight from the folks at Envista:
DEXIS will combine other leading brands including i-CAT, Gendex, Instrumentarium, SOREDEX, and NOMAD, which with DEXIS are pioneers in x-ray generation, digital intraoral radiography, panoramic and cephalometric imaging, and 3D CBCT imaging. We have one of the largest installed bases of dental imaging devices in the industry with over 150,000 imaging devices currently utilized in dental practices. End-users of imaging devices can utilize our new diagnostics and treatment planning software suite DTX Studio to access all clinical patient images in one place, using one software.
Envista Holdings Corporation CEO Amir Aghdaei said, "We are excited to unite our imaging portfolio under the DEXIS brand and unveil our new DEXIS logo that will be featured on our entire imaging portfolio. This is one step in our continued efforts to create integrated, digital workflows that connect all our products and enable dental professionals to treat and improve more patient lives. We are living out our strategy to digitize, personalize, and democratize dentistry and look forward to the future."
Headquartered in the United States, DEXIS is present in over 50 countries and has a workforce of approximately 1,000 employees. Over the rest of 2022, the imaging portfolio will transition in branding from KaVo to DEXIS with different schedules by product and by region. DEXIS continues to value its distributor partnerships and is excited to partner with distributors around the world to bring end-to-end, digital, diagnostic workflow solutions to dental professionals.
The DEXIS sales and service teams can be reached at www.DEXIS.com. Learn more at www.DEXIS.com or @DEXISimaging on Facebook, Instagram, or LinkedIn.
About Envista Holdings Corporation
Envista is a global family of more than 30 trusted dental brands, including Nobel Biocare, Ormco, and Kerr united by a shared purpose: to partner with professionals to improve lives. Envista helps its customers deliver the best possible patient care through industry-leading dental consumables, solutions, technology, and services. Our comprehensive portfolio, including dental implants and treatment options, orthodontics, and digital imaging technologies, covers a broad range of dentists' clinical needs for diagnosing, treating, and preventing dental conditions as well as improving the aesthetics of the human smile. With a foundation comprised of the proven Envista Business System (EBS) methodology, an experienced leadership team, and a strong culture grounded in continuous improvement, commitment to innovation, and deep customer focus, Envista is well equipped to meet the end-to-end needs of dental professionals worldwide. Envista is one of the largest global dental products companies, with significant market positions in some of the most attractive segments of the dental products industry. For more information, please visit www.envistaco.com.
No comments:
Post a Comment